Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 122 participants.
Also called NCT01474538
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 122 participants
- Sponsor
- Registry
-
NCT01474538
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01474538. Randomized; triple masking; primary purpose treatment. Start 2011-12 (registry gives no type); primary completion 2013-02 (actual). Results posted on 2014-03-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Insulin Lispro
- Intervention (Drug)
- Insulin Aspart
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct01474538- Content hash
7548dbe621005e35a38b5e03f9a989e71daefed1c0b7d4f68cdeeb0a91aa6ad4